Trials / Completed
CompletedNCT02565238
BIO.MASTER.BioMonitor 2 Study
Master Study of the Insertable Cardiac Monitor BioMonitor 2.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 92 (actual)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to confirm safety and efficacy of the BioMonitor 2. The data is collected to support the regulatory approval of this product in countries outside the CE region.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BioMonitor 2 | Implantation of BioMonitor 2 |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-10-01
- Completion
- 2017-02-01
- First posted
- 2015-10-01
- Last updated
- 2017-05-08
Source: ClinicalTrials.gov record NCT02565238. Inclusion in this directory is not an endorsement.